These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 26101697)

  • 1. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.
    Wang Q; Holst J
    Am J Cancer Res; 2015; 5(4):1281-94. PubMed ID: 26101697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of system L amino acid transporter subtypes in rat placenta and yolk sac.
    Owaydhah WH; Ashton N; Verrey F; Glazier JD
    Placenta; 2021 Jan; 103():188-198. PubMed ID: 33160252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.
    Hayashi K; Anzai N
    World J Gastrointest Oncol; 2017 Jan; 9(1):21-29. PubMed ID: 28144396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and Insulin-like growth factor-I (IGF-I) modulate the expression of L-type amino acid transporters in the muscles of spontaneous dwarf rats and L6 and C2C12 myocytes.
    Sawa R; Nishida H; Yamamoto Y; Wake I; Kai N; Kikkawa U; Okimura Y
    Growth Horm IGF Res; 2018; 42-43():66-73. PubMed ID: 30273774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of Thyroid Hormone Transport by l-Type Amino Acid Transporter.
    Krause G; Hinz KM
    Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):379-382. PubMed ID: 31739345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of Iodothyronines by Human L-Type Amino Acid Transporters.
    Zevenbergen C; Meima ME; Lima de Souza EC; Peeters RP; Kinne A; Krause G; Visser WE; Visser TJ
    Endocrinology; 2015 Nov; 156(11):4345-55. PubMed ID: 26305885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and -LAT2, and LAT1 and LAT2 Substrates and Inhibitors.
    Kantipudi S; Fotiadis D
    Front Mol Biosci; 2021; 8():676854. PubMed ID: 34124158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
    Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
    J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.
    Shindo H; Harada-Shoji N; Ebata A; Sato M; Soga T; Miyashita M; Tada H; Kawai M; Kosaka S; Onuki K; Usami S; Furumoto S; Hayashi S; Abe T; Suzuki T; Ishida T; Sasano H
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF-activated PI3K/Akt signalling coordinates leucine uptake by regulating LAT3 expression in prostate cancer.
    Zhang BK; Moran AM; Bailey CG; Rasko JEJ; Holst J; Wang Q
    Cell Commun Signal; 2019 Jul; 17(1):83. PubMed ID: 31345230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth.
    Wang Q; Grkovic T; Font J; Bonham S; Pouwer RH; Bailey CG; Moran AM; Ryan RM; Rasko JE; Jormakka M; Quinn RJ; Holst J
    ACS Chem Biol; 2014 Jun; 9(6):1369-76. PubMed ID: 24762008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters.
    Otsuki H; Kimura T; Yamaga T; Kosaka T; Suehiro JI; Sakurai H
    Prostate; 2017 Feb; 77(2):222-233. PubMed ID: 27696482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
    Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
    Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
    Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
    Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
    Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
    Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
    Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
    J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of the system L neutral amino acid transporter (LAT) promote endothelial adhesivity of human red blood cells.
    Dosier LBM; Premkumar VJ; Zhu H; Akosman I; Wempe MF; McMahon TJ
    Thromb Haemost; 2017 Jun; 117(7):1402-1411. PubMed ID: 28382373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The small SLC43 family: facilitator system l amino acid transporters and the orphan EEG1.
    Bodoy S; Fotiadis D; Stoeger C; Kanai Y; Palacín M
    Mol Aspects Med; 2013; 34(2-3):638-45. PubMed ID: 23268354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
    Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
    J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
    Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.